A First-In-Human Study of ARO-033 in Adult Participants

Clinical trial NCT07662096 · RECRUITING

Trial details

NCT number: NCT07662096
Sponsor: Arrowhead Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2026-06-25
Primary completion: 2027-07-18
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.